|
rdf:type |
|
|
lifeskim:mentions |
umls-concept:C0008943,
umls-concept:C0014180,
umls-concept:C0034380,
umls-concept:C0034656,
umls-concept:C0039286,
umls-concept:C0042149,
umls-concept:C0043210,
umls-concept:C0231221,
umls-concept:C0232970,
umls-concept:C0290883,
umls-concept:C0392747,
umls-concept:C0443172
|
|
pubmed:issue |
2
|
|
pubmed:dateCreated |
2011-1-28
|
|
pubmed:abstractText |
Before the knowledge that 5 years of adjuvant tamoxifen is less efficacious than 2 to 3 years of tamoxifen followed by 2 to 3 years of anastrozole/exemestane, we designed a multicenter double-blind randomized controlled trial in women taking tamoxifen with a thickened endometrium to compare uterine and quality-of-life parameters between those switching to anastrozole and those continuing tamoxifen.
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Feb
|
|
pubmed:issn |
1530-0374
|
|
pubmed:author |
pubmed-author:AmantFrédéricF,
pubmed-author:BertelootPatrickP,
pubmed-author:BlommeChantalC,
pubmed-author:De JongeEricE,
pubmed-author:DepypereHermanH,
pubmed-author:NevenPatrickP,
pubmed-author:TimmermanDirkD,
pubmed-author:Van CalsterBenB,
pubmed-author:Van GinderachterJohanJ,
pubmed-author:Van HuffelSabineS,
pubmed-author:Van de PutteGreggG,
pubmed-author:Van den BroeckeRudyR,
pubmed-author:VergoteIgnaceI,
pubmed-author:VlaemynckGeertG,
pubmed-author:VlasselaerJosJ
|
|
pubmed:issnType |
Electronic
|
|
pubmed:volume |
18
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
224-9
|
|
pubmed:meshHeading |
pubmed-meshheading:20881891-Aged,
pubmed-meshheading:20881891-Antineoplastic Agents, Hormonal,
pubmed-meshheading:20881891-Aromatase Inhibitors,
pubmed-meshheading:20881891-Breast Neoplasms,
pubmed-meshheading:20881891-Double-Blind Method,
pubmed-meshheading:20881891-Female,
pubmed-meshheading:20881891-Humans,
pubmed-meshheading:20881891-Middle Aged,
pubmed-meshheading:20881891-Nitriles,
pubmed-meshheading:20881891-Postmenopause,
pubmed-meshheading:20881891-Quality of Life,
pubmed-meshheading:20881891-Sexual Dysfunction, Physiological,
pubmed-meshheading:20881891-Tamoxifen,
pubmed-meshheading:20881891-Treatment Outcome,
pubmed-meshheading:20881891-Triazoles,
pubmed-meshheading:20881891-Uterus
|
|
pubmed:year |
2011
|
|
pubmed:articleTitle |
Uterine and quality of life changes in postmenopausal women with an asymptomatic tamoxifen-thickened endometrium randomized to continuation of tamoxifen or switching to anastrozole.
|
|
pubmed:affiliation |
Department of Electrical Engineering (ESAT-SCD), Katholieke Universiteit Leuven, Leuven, Belgium. ben.vancalster@esat.kuleuven.be
|
|
pubmed:publicationType |
Journal Article,
Randomized Controlled Trial,
Research Support, Non-U.S. Gov't,
Multicenter Study
|
